Charlotte J Frise

Dr. Charlotte J Frise

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2021 in Anaesthesia
Verified
Journal Article
Open access
PDF file
CBC. S. Benson
C. S. Benson
ASAkshay Shah
Akshay Shah
SSS. J. Stanworth
S. J. Stanworth
CFCharlotte J Frise
Charlotte J Frise
HSH. Spiby
H. Spiby
AKA. A. Klein
A. A. Klein
Summary: Iron deficiency and anaemia are global health problems and major causes of morbidity in women. Current definitions of anaemia in women are historic and have been challenged by recent data from observational studies. Menstrual loss, abnormal uterine bleeding and pregnancy put women at risk of developing iron deficiency which can result in severe fatigue, reduced exercise capacity and poor work performance. Iron deficiency and anaemia during pregnancy are associated with adverse maternal and fetal outcomes, including neurocognitive deficits in children born to iron‐deficient mothers. Both iron deficiency and anaemia are common in women undergoing surgery but their association with poor outcomes remains uncertain. The enduring burden of iron deficiency and anaemia in women suggests that current strategies for recognition, prevention and treatment are limited in their utility. Improvements in our understanding of iron homeostasis and the development of new iron preparations, which are better absorbed with fewer side‐effects, may improve therapeutic effectiveness of oral iron. Intravenous iron is efficacious for correcting anaemia rapidly but high‐quality data on patient‐centred outcomes and cost‐effectiveness are currently lacking. Many recommendations for the treatment of iron deficiency and anaemia in national guidelines are not supported by high‐quality evidence. There is a need for robust epidemiological data and well‐designed clinical trials. The latter will require collaborative working between researchers and patients to design studies in ways that incorporate patients’ perspectives on the research process and target outcomes that matter to them.

1 March 2013 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
CFCharlotte J Frise
Charlotte J Frise
LMLucy Mackillop
Lucy Mackillop
KJKaren Joash
Karen Joash
CWCatherine Williamson
Catherine Williamson

1 January 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
CFCharlotte J Frise
Charlotte J Frise
APAlex Pitcher
Alex Pitcher
LMLucy Mackillop
Lucy Mackillop

1 April 2013 in Clinical Medicine
Verified
Journal Article
Open access
PDF file
CFCharlotte J Frise
Charlotte J Frise
CWCatherine Williamson
Catherine Williamson
Endocrine disease is common in pregnancy. Most pre-existing endocrine conditions, if well controlled, have little impact on maternal or fetal morbidity. Uncontrolled endocrine conditions in pregnancy, whether poorly controlled pre-conception or newly diagnosed, are associated with a variety of adverse fetal outcomes and maternal morbidity. Also, transplacental transfer of maternal antibodies can have adverse fetal or neonatal consequences. The initial diagnosis of many conditions is hindered by the overlap of symptoms that occur in normal pregnancy and those that suggest specific endocrine pathologies, and also by the changes in reference ranges for common biochemical measurements that occur as a result of physiological changes in pregnancy. This article summarises the common endocrine disorders in pregnancy and describes how pregnancy can alter their investigation, treatment and ongoing management, as well as the potential effects on the fetus.

24 December 2015 in Obstetric Medicine
Verified
Journal Article
Open access
PDF file
CFCharlotte J Frise
Charlotte J Frise
BABen Attwood
Ben Attwood
PWPeter Watkinson
Peter Watkinson
LMLucy Mackillop
Lucy Mackillop
Pregnancy is an insulin resistant state. Hyperglycaemia and gestational diabetes mellitus are well-recognised complications even in women without existing metabolic syndrome or obesity. Pregnant women also appear to be more vulnerable to ketoacidosis, particularly after short periods of reduced oral intake in the third trimester, and may present with very severe starvation ketoacidosis, prompting emergent delivery. We present a case of a woman with a background of depression and psychotic episodes. Olanzapine had been commenced after a psychotic episode at 20 weeks’ gestation. Gestational diabetes mellitus was diagnosed at 28 weeks, and she was then admitted at 31 weeks with severe euglycaemic ketoacidosis following a short period of vomiting. She underwent caesarean section when the metabolic disturbances did not resolve with medical treatment. We believe atypical antipsychotic therapy contributed to the profound insulin resistance seen here, and that obstetricians, physicians and psychiatrists must be aware of the risks conferred by these agents in pregnancy.

1 June 2013 in Clinical Medicine
Verified
Journal Article
Open access
PDF file
CFCharlotte J Frise
Charlotte J Frise
CWCatherine Williamson
Catherine Williamson
Gastrointestinal (GI) conditions are common in women of childbearing age. They often present before pregnancy but can arise de novo during pregnancy. The physiological changes that occur during pregnancy can influence the differential diagnosis of common GI presentations, affect the interpretation of diagnostic tests and restrict the use of diagnostic or therapeutic procedures. In this article, we summarise the clinical features, investigation and management of common GI and liver conditions that are incidental to pregnancy, and describe the specific features of pregnancy-related disorders that are less frequently encountered by general physicians. Newer developments in areas that are increasingly encountered in obstetric medical practice, including pregnancy after bariatric procedures, are also described.